Kura Oncology, Inc.
KURA
Stephen Dale
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stephen Dale
The proxy statement of Kura Oncology, Inc. reports total compensation of $2,508,675 for Stephen Dale in fiscal 2024, including a base salary of $575,140. Disclosed compensation is on record for 5 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Kura Oncology, Inc. (KURA)
Proxy statement
Start not stated–2025-04-11
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Kura Oncology, Inc. (KURA) | Former Chief Medical Officer | $575,140 | $2,508,675 |
| 2023 | Kura Oncology, Inc. (KURA) | Former Chief Medical Officer | $538,264 | $2,465,473 |
| 2022 | Kura Oncology, Inc. (KURA) | Former Chief Medical Officer | $463,600 | $3,443,477 |
| 2021 | Kura Oncology, Inc. (KURA) | Chief Medical Officer | $489,014 | $2,928,682 |
| 2020 | Kura Oncology, Inc. (KURA) | Chief Medical Officer | $158,602 | $3,286,154 |
Recent activity
No call appearances or filed executive changes recorded yet.